FR2539128B1 - - Google Patents

Info

Publication number
FR2539128B1
FR2539128B1 FR8300273A FR8300273A FR2539128B1 FR 2539128 B1 FR2539128 B1 FR 2539128B1 FR 8300273 A FR8300273 A FR 8300273A FR 8300273 A FR8300273 A FR 8300273A FR 2539128 B1 FR2539128 B1 FR 2539128B1
Authority
FR
France
Prior art keywords
radical
radicals
alkyl
optionally substituted
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8300273A
Other languages
English (en)
French (fr)
Other versions
FR2539128A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR8300273A priority Critical patent/FR2539128A1/fr
Priority to AT84400023T priority patent/ATE41661T1/de
Priority to DE8484400023T priority patent/DE3477382D1/de
Priority to EP84400023A priority patent/EP0114128B1/fr
Priority to ES528742A priority patent/ES8407046A1/es
Priority to GR73456A priority patent/GR79459B/el
Priority to DK007584A priority patent/DK164404C/da
Priority to CA000444923A priority patent/CA1244034A/fr
Priority to IE36/84A priority patent/IE56521B1/en
Priority to JP59001419A priority patent/JPS59130862A/ja
Priority to PT77939A priority patent/PT77939B/pt
Publication of FR2539128A1 publication Critical patent/FR2539128A1/fr
Application granted granted Critical
Publication of FR2539128B1 publication Critical patent/FR2539128B1/fr
Priority to JP2288631A priority patent/JPH0678336B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8300273A 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation Granted FR2539128A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR8300273A FR2539128A1 (fr) 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
DE8484400023T DE3477382D1 (en) 1983-01-10 1984-01-06 3-amino-2-oxo-azetidine derivatives containing in position 1 a nitrogen heterocyclic radical, process for their preparation, their use as therapeutical agents and intermediates for their preparation
EP84400023A EP0114128B1 (fr) 1983-01-10 1984-01-06 Nouveaux dérivés de la 3-amino 2-oxoazétidine comportant en position 1, un radical hétérocyclique azoté, leur procédé de préparation, leur application comme médicaments et les produits intermédiaires nécessaires à leur préparation
AT84400023T ATE41661T1 (de) 1983-01-10 1984-01-06 3-amino-2-oxo-azetidin-derivate enthaltend in 1- stellung einen stickstoffhaltigen heterocyclischen ring, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und die zwischenprodukte zu ihrer herstellung.
GR73456A GR79459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-01-10 1984-01-09
DK007584A DK164404C (da) 1983-01-10 1984-01-09 3-amino-2-oxo-azetidinderivater, analogifremgangsmaade til fremstilling deraf samt laegemidler indeholdende derivaterne
ES528742A ES8407046A1 (es) 1983-01-10 1984-01-09 Procedimiento para preparar nuevos derivados de la 3-amino-2-oxoazetidina
CA000444923A CA1244034A (fr) 1983-01-10 1984-01-09 Procede pour la preparation de derives de la 3-amino 2-oxo-azetidine comportant en position 1 un radical heterocyclique azote, et les derives ainsi obtenus
IE36/84A IE56521B1 (en) 1983-01-10 1984-01-10 Azetidines
JP59001419A JPS59130862A (ja) 1983-01-10 1984-01-10 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体、それらの製造方法及び抗菌剤
PT77939A PT77939B (fr) 1983-01-10 1984-01-10 Procede de preparation de nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un heterocycle azote
JP2288631A JPH0678336B2 (ja) 1983-01-10 1990-10-29 窒素複素環式基を1位置に有する3―アミノ―2―オキソアゼチジンの新誘導体及びそれらの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300273A FR2539128A1 (fr) 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Publications (2)

Publication Number Publication Date
FR2539128A1 FR2539128A1 (fr) 1984-07-13
FR2539128B1 true FR2539128B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-05-03

Family

ID=9284799

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8300273A Granted FR2539128A1 (fr) 1983-01-10 1983-01-10 Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Country Status (11)

Country Link
EP (1) EP0114128B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPS59130862A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE41661T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1244034A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3477382D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK164404C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8407046A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2539128A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR79459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE56521B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT77939B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0649696B2 (ja) * 1983-07-04 1994-06-29 富山化学工業株式会社 新規なアゼチジノン誘導体およびその塩類
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
JPH07108907B2 (ja) * 1984-06-25 1995-11-22 富山化学工業株式会社 新規なアゼチジノン誘導体またはその塩
JPH075592B2 (ja) * 1984-06-25 1995-01-25 富山化学工業株式会社 新規なアゼチジノン誘導体およびその塩
FR2582308B1 (fr) * 1985-05-22 1987-10-09 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical tetrazolyle substitue par un radical organique clivable, leur procede de preparation et leur application comme medicaments
FR2585021B2 (fr) * 1985-07-18 1989-05-19 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidinone comportant, en position 1, un radical heterocyclique azote, leur procede de preparation et leur application comme medicaments
EP0344197B1 (en) * 1987-02-11 1991-08-14 The Upjohn Company Novel n-1 substituted beta-lactams as antibiotics
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
US5001235A (en) * 1987-02-27 1991-03-19 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
AU2125188A (en) * 1987-07-22 1989-02-13 Upjohn Company, The Therapeutically useful beta-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
CN103012316B (zh) * 2012-11-29 2015-03-25 浙江工业大学 N-4-甲基-1,2,3-噻二唑-4-酰基-n-取代1,3,4-噻二唑基硫脲衍生物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468874A (en) * 1967-04-10 1969-09-23 R & L Molecular Research Ltd 6 - tetrazolylacetamido penicillanic and 7-tetrazolylacetamido cephalosporanic acids
US4186131A (en) * 1977-04-21 1980-01-29 Mead Johnson & Company Phenyltetrazolyloxy propanolamines
DE2946432A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Tetrazolyloxycarbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS588060A (ja) * 1981-06-29 1983-01-18 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド アリ−ルチオアゼチジノンスルホン酸塩類

Also Published As

Publication number Publication date
JPS59130862A (ja) 1984-07-27
ES528742A0 (es) 1984-08-16
IE56521B1 (en) 1991-08-28
EP0114128A1 (fr) 1984-07-25
DK164404C (da) 1992-11-09
ATE41661T1 (de) 1989-04-15
JPH03163076A (ja) 1991-07-15
GR79459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-30
JPH0480912B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-12-21
FR2539128A1 (fr) 1984-07-13
CA1244034A (fr) 1988-11-01
JPH0678336B2 (ja) 1994-10-05
EP0114128B1 (fr) 1989-03-22
PT77939B (fr) 1986-06-18
PT77939A (fr) 1984-02-01
DE3477382D1 (en) 1989-04-27
IE840036L (en) 1984-07-10
ES8407046A1 (es) 1984-08-16
DK7584A (da) 1984-07-11
DK164404B (da) 1992-06-22
DK7584D0 (da) 1984-01-09

Similar Documents

Publication Publication Date Title
FR2539128B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA2143636A1 (en) Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
EP0496561A3 (en) (((2-amino-3,4-dioxo-1-cyclo-buten-1-yl)amino)alkyl)-acid derivatives
FI102281B1 (fi) Menetelmä uusien erytromysiinijohdannaisten valmistamiseksi
AU5700886A (en) (Meth)-acrylic acid esters and their use
AU7189094A (en) Acetamide derivatives and their use for modifying feeding behavior modifiers
KR930002327A (ko) 치환된 시클로프로필아미노-1, 3, 5-트리아진
ATE132849T1 (de) Neue 3,5-di-tert.butyl-4-hydroxyphenyl-derivate, verfahren zu ihrer herstellung und arzneimittel
ATE192143T1 (de) Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ZA894777B (en) New substituted sulphonamides
ATE167187T1 (de) Chinuclidinestern, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
FI935318A0 (fi) 15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi
DE3881407D1 (de) Cinnolin-karbonsaeure-amide und verfahren zu deren herstellung.
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
ATE112283T1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE195145T1 (de) Synthese von homochiralen 2-hydroxysäuren
ATE238660T1 (de) Triazolyloxybenzyl-alkoxyacrylsäureester, verfahren zu ihrer herstellung und ihre verwendung
DE3768469D1 (de) N-substituierte, estergruppen enthaltende acrylamide.
ATE47839T1 (de) N-(2,6-disubstituierte aryl)-n'pyridinylharnstoffe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
ATE121397T1 (de) Aminoalkylketonderivate, verfahren zu ihrer herstellung und ihre therapeutischen anwendungen.
HUT36788A (en) Process for producing s-alkenyl-esters of thiol-carbamoic acids

Legal Events

Date Code Title Description
ST Notification of lapse